{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:41:30Z","timestamp":1792644090362,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019920","name":"Soci\u00e9t\u00e9 d'Acc\u00e9l\u00e9ration du Transfert de Technologies","doi-asserted-by":"publisher","award":["SEAPAL"],"award-info":[{"award-number":["SEAPAL"]}],"id":[{"id":"10.13039\/501100019920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-12-ASTR-003"],"award-info":[{"award-number":["ANR-12-ASTR-003"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-23-ASTR-0005"],"award-info":[{"award-number":["ANR-23-ASTR-0005"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016398","name":"Minist\u00e8re des Arm\u00e9es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010095","name":"Hauts-de-France Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018833","name":"French Government Defense Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014161","name":"Conseil R\u00e9gional Hauts-de-France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014161","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119349","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:15:44Z","timestamp":1790291744000},"page":"119349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel enantiopure pyridine-based aminoalcohols as promising antimalarial candidates"],"prefix":"10.1016","volume":"320","author":[{"given":"Aur\u00e9lie","family":"Herrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Tisnerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8589-3965","authenticated-orcid":false,"given":"Guillaume","family":"Bentzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1923-5315","authenticated-orcid":false,"given":"Etienne","family":"Pair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bouchut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1277-7728","authenticated-orcid":false,"given":"Romain","family":"Musti\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Gosselet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mulli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Agnamey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8631-1015","authenticated-orcid":false,"given":"Nicolas","family":"Taudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pradines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2891-9102","authenticated-orcid":false,"given":"Alexandra","family":"Dassonville-Klimpt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0118-9151","authenticated-orcid":false,"given":"Pascal","family":"Sonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119349_bib1","author":"World Health Organization"},{"key":"10.1016\/j.ejmech.2026.119349_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4269\/ajtmh.1991.45.86","article-title":"Neuropsychiatric side effects after the use of mefloquine","volume":"45","author":"Weinke","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2026.119349_bib3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.2042-7158.1997.tb06047.x","article-title":"Ch. Crevoisier, F. Gimenez, R. Farinotti, stereoselective passage of mefloquine through the blood-brain barrier in the rat","volume":"49","author":"Baudry","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119349_bib4","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/sj.bjp.0705721","article-title":"Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice","volume":"141","author":"de Lagerie","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119349_bib5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/AAC.50.3.1045-1053.2006","article-title":"Mefloquine induces dose-related neurological effects in a rat model","volume":"50","author":"Dow","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119349_bib6","first-page":"57","article-title":"Central anticholinergic syndrome with the antimalarial drug mefloquine, N. Engl","volume":"331","author":"Speich","year":"1994","journal-title":"J. Med."},{"key":"10.1016\/j.ejmech.2026.119349_bib7","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1212\/01.WNL.0000095581.20961.7D","article-title":"Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease","volume":"61","author":"Weiss","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2026.119349_bib8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.bjp.0703638","article-title":"The antimalarial agent mefloquine inhibits ATP-sensitive K-channels,","volume":"131","author":"Gribble","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.ejmech.2026.119349_bib9","article-title":"The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro,","volume":"2","author":"Dow","year":"2003","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2026.119349_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4269\/ajtmh.1984.33.767","article-title":"Evaluation of the 4-pyridinemethanol WR 180,409 (enpiroline) in the treatment of induced Plasmodium falciparum infections in healthy, non-immune subjects","volume":"33","author":"Cosgriff","year":"1984","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2026.119349_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/AAC.14.3.420","article-title":"Antimalarial activities of various 4-pyridinemethanols with special attention to WR-172,435 and WR-180,409","volume":"14","author":"Schmidt","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119349_bib12","series-title":"4-Aminoalcoholquinoline Derivatives, Enantioselective Synthesis Methods and the Use Thereof, WO 2012\/107532 A1","author":"Jonet","year":"2012"},{"issue":"65","key":"10.1016\/j.ejmech.2026.119349_bib13","article-title":"Differences in anti-malarial activity of 4-aminoalcohol quinoline enantiomers and investigation of the presumed underlying mechanism of action","volume":"11","author":"Mulli\u00e9","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2026.119349_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/cplu.201300074","article-title":"Absolute configuration and antimalarial activity of erythro -mefloquine enantiomers","volume":"78","author":"Dassonville-Klimpt","year":"2013","journal-title":"ChemPlusChem"},{"key":"10.1016\/j.ejmech.2026.119349_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-13-407","article-title":"Enantiomerically pure amino-alcohol quinolines: in vitro anti-malarial activity in combination with dihydroartemisinin, cytotoxicity and in vivo efficacy in a Plasmodium berghei mouse model","volume":"13","author":"Mulli\u00e9","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2026.119349_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tetasy.2015.11.003","article-title":"Asymmetric synthesis of new antimalarial aminoquinolines through Sharpless aminohydroxylation","volume":"27","author":"Bentzinger","year":"2016","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.ejmech.2026.119349_bib17","article-title":"Novel aminopyridinemethanol and their use","author":"Sonnet","year":"2019","journal-title":"WO 2019\/086614 A1"},{"key":"10.1016\/j.ejmech.2026.119349_bib18","doi-asserted-by":"crossref","first-page":"131088","DOI":"10.1016\/j.tet.2020.131088","article-title":"Enantiopure substituted pyridines as promising antimalarial drug candidates","volume":"76","author":"Bentzinger","year":"2020","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2026.119349_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113981","article-title":"Design, synthesis, and characterization of novel aminoalcohol quinolines with strong in vitro antimalarial activity","volume":"228","author":"Dassonville-Klimpt","year":"2022","journal-title":"Eur. J. Med. Chem"},{"key":"10.1016\/j.ejmech.2026.119349_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2026.119349_bib21","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119349_bib22","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/AAC.48.5.1807-1810.2004","article-title":"Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy","volume":"48","author":"Bennett","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119349_bib23","first-page":"443","article-title":"Metabolism of fluorine-containing drugs, Annu. Rev. Pharmacol","volume":"41","author":"Park","year":"2001","journal-title":"Toxicol"},{"key":"10.1016\/j.ejmech.2026.119349_bib24","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/jm00389a008","article-title":"Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases","volume":"30","author":"Manoury","year":"1987","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119349_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/00498250210128675","article-title":"Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells","volume":"32","author":"Rodr\u00edguez-Antona","year":"2002","journal-title":"Xenobiotica Fate Foreign Compd. Biol. Syst"},{"key":"10.1016\/j.ejmech.2026.119349_bib26","first-page":"1404","article-title":"A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells, Hum","volume":"18","author":"Hovatta","year":"2003","journal-title":"Reprod"},{"key":"10.1016\/j.ejmech.2026.119349_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14728222.10.2.319","article-title":"QPatch: the past, present and future of automated patch clamp","volume":"10","author":"Mathes","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2026.119349_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-3565(24)36999-X","article-title":"The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data,","volume":"283","author":"Obach","year":"1997","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.119349_bib29","author":"Oecd"},{"key":"10.1016\/j.ejmech.2026.119349_bib30","series-title":"Trifluoromethyl substituted-2,6-diphenyl-4-pyridyl Carbinolamine Antimalarials","author":"Ash","year":"1973"},{"key":"10.1016\/j.ejmech.2026.119349_bib31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4269\/ajtmh.2009.09-0394","article-title":"Therapeutic efficacy and effects of artesunate-mefloquine and mefloquine alone on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in southwest Nigeria","volume":"81","author":"Sowunmi","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2026.119349_bib32","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/315141","article-title":"In vivo efficacy of mefloquine for the treatment of Falciparum malaria in Brazil","volume":"180","author":"Cerutti","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119349_bib33","first-page":"173","article-title":"Revised methods for the salmonella mutagenicity test, mutat. Res. Mutagen. Relat","volume":"113","author":"Maron","year":"1983","journal-title":"Subjectivity"},{"key":"10.1016\/j.ejmech.2026.119349_bib34","first-page":"1","article-title":"Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells, mutat. Res. Toxicol. Environ","volume":"630","author":"Diaz","year":"2007","journal-title":"Mutagenesis"},{"key":"10.1016\/j.ejmech.2026.119349_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099733","article-title":"A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells","volume":"9","author":"Cecchelli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119349_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400790","article-title":"Synthesis of new enantiopure aminoalcohol fluorenes as promising pntimalarial compounds","volume":"20","author":"Tisnerat","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119349_bib37","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.16.6.710","article-title":"Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique","volume":"16","author":"Desjardins","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119349_bib38","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1128\/AAC.00367-06","volume":"50","author":"Kaddouri","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119349_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-1759(93)90011-U","article-title":"The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity,","volume":"160","author":"Crouch","year":"1993","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejmech.2026.119349_bib40","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/1087057112441013","article-title":"In Vitro ADME profiling using high-throughput RapidFire mass spectrometry: Cytochrome P450 inhibition and metabolic stability assays","volume":"17","author":"Wu","year":"2012","journal-title":"SLAS Discov"},{"key":"10.1016\/j.ejmech.2026.119349_bib41","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/infdis\/jir033","article-title":"Substantially reduced pre-patent parasite multiplication rates are associated with naturally acquired immunity to Plasmodium falciparum","volume":"203","author":"Douglas","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119349_bib42","first-page":"278","article-title":"Protective role of platelets in chronic (Balb\/C) and acute (CBA\/J) Plasmodium berghei murine malaria","volume":"27","author":"Polack","year":"1997","journal-title":"Haemostasis"},{"key":"10.1016\/j.ejmech.2026.119349_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016114","article-title":"Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells","volume":"6","author":"Pedroso","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119349_bib44","doi-asserted-by":"crossref","unstructured":"E. Vandenhaute, L. Dehouck, M.-C. Boucau, E. Sevin, R. Uzbekov, M. Tardivel, F. Gosselet, L. Fenart, R. Cecchelli, M.-P. Dehouck, Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes, Curr. Neurovasc. Res. 8 (n.d.) 258\u2013269. https:\/\/doi.org\/10.2174\/156720211798121016.","DOI":"10.2174\/156720211798121016"},{"key":"10.1016\/j.ejmech.2026.119349_bib45","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.3390\/cells11243963","article-title":"Quantitative targeted absolute proteomics for better characterization of an in vitro human blood\u2013brain barrier model derived from hematopoietic stem cells","volume":"11","author":"Dehouck","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119349_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.119023","article-title":"Design, synthesis and evaluation of an uncharged broad spectrum quinoline-oxime hybrid for the reactivation of nerve agent-inhibited human acetylcholinesterase","volume":"316","author":"De Sousa","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119349_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(98)00083-0","article-title":"In vitro model for evaluating drug transport across the blood\u2013brain barrier","volume":"36","author":"Cecchelli","year":"1999","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:28:21Z","timestamp":1792643301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":47,"alternative-id":["S0223523426007944"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119349","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel enantiopure pyridine-based aminoalcohols as promising antimalarial candidates","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119349"}}